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Abstract The insertion/deletion (I/D) polymorphism in intron 16 of the angiotensin I-converting enzyme gene (ACE) has been ex-
tensively studied as a predisposing factor for idiopathic recurrent spontaneous abortion (IRSA). A case-control study including 149
women with ≥3 spontaneous abortions and 149 controls was performed to test the association of ACE I/D polymorphism with IRSA. A
systematic review was conducted of previous case-control studies, with strict selection criteria for meta-analyses. We also aimed
to evaluate the potential differences in summary estimates between studies deﬁning IRSA as ≥2 and ≥3 spontaneous abortions. Genotyping
was performed by PCR, and systematic review conducted using PubMed and Scopus. There was no association of the polymorphism
with IRSA in Slovenian women. Sixteen case-control studies, showing substantial differences regarding IRSA deﬁnition and selection
criteria for women were identiﬁed. Meta-analysis was performed and included four studies deﬁning IRSA as ≥2 spontaneous abor-
tions and the current study, which deﬁned IRSA as ≥3 spontaneous abortions. Based on random effects model, meta-analysis con-
ducted on 1192 patients and 736 controls showed no association with IRSA under dominant(DD+IDvsII) and recessive(DDvsID+II) genetic models.
Well-designed studies are needed to evaluate the role of ACE I/D polymorphism in IRSA deﬁned as ≥3 spontaneous abortions.
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Introduction
The renin-angiotensin system (RAS) is an important regula-
tor of human pregnancy, during which the maternal and fetal
circulating RAS interact with various tissue RAS, including those
of the ovaries and fetoplacental unit (Irani and Xia, 2011;
Lumbers and Pringle, 2014). At the systemic level, the RAS
is involved in the regulation of blood pressure and volume,
haemostasis and homeostasis of water and electrolytes,
whereas at the fetoplacental unit it inﬂuences implanta-
tion, placentation, angiogenesis and uteroplacental blood ﬂow
(Irani and Xia, 2011; Lumbers and Pringle, 2014; Nielsen et al.,
2000). Therefore, abnormalities in the RAS have been sug-
gested as a potential contributing mechanism to different preg-
nancy complications, including idiopathic recurrent
spontaneous abortion (IRSA).
According to the evidence-based guidelines for the inves-
tigation and treatment of RSA, the condition is character-
ized by three or more (≥3) consecutive spontaneous abortions
(Jauniaux et al., 2006), althoughmany scientiﬁc groups include
couples with two or more (≥2) spontaneous abortions in their
research. The aetiology of RSA cannot be determined in ap-
proximately 60% of cases. Considering that the expression of
genes encoding RAS components, including renin,
angiotensinogen (AGT), angiotensin I-converting enzyme (ACE),
AGT II type 1 and 2 receptors (AGT1R, AGT2R), is in part in-
ﬂuenced by gene variations (Jeunemaitre, 2008), a large
number of studies investigated their association with IRSA.
The insertion/deletion (I/D) of a 287 bp sequence in intron
16 of the ACE gene is the most commonly tested variation;
however, there is no conclusive evidence on its role in the
pathogenesis of IRSA.
Angiotensin I-converting enzyme is a zinc metallopeptidase
that converts the inactive angiotensin I to active angioten-
sin II (ANG II), and in addition cleaves bradykinin and several
other peptides (Masuyer et al., 2014). Although the ACE I/D
polymorphism in intron 16 is associated with alterations in cir-
culating and tissue concentrations of ACE, evidence sug-
gests that it is not a functional polymorphism, but is linked
with other, yet unknown, intragenic functional variations
(Sayed-Tabatabaei et al., 2006). Nevertheless, the DD geno-
type is accompanied by increased serum ACE and plasmino-
gen activator inhibitor-1 (PAI-1) concentrations compared with
the II genotype (Rigat et al., 1990; Tiret et al., 1992).
According to the ﬁrst genetic-association study, the as-
sumption for a possible association between the ACE I/D poly-
morphism in intron 16 and IRSA was based on the well-
known roles of ANG II in the control of vascular tone and
ﬁbrinolysis, which, if disturbed, might lead to abnormal de-
velopment of placental vasculature and disturbances of
haemostasis (Fatini et al., 2000). Afterwards, a series of studies
in different populations continued the search for a poten-
tial association, but results did not conﬁrm one. A qualita-
tive and quantitative synthesis of results was performed in
three studies; however, we observed that the process of study
selection was not performed in accordance with the pro-
posed eligibility criteria (Su et al., 2013; Wang et al., 2013;
Yang et al., 2012). Therefore, we performed a case-control
study to test the association of ACE I/D polymorphism in intron
16 with IRSA in Slovenian women and conducted a thorough
systematic review of previous case-control studies. Finally,
based on precisely chosen inclusion criteria for meta-analyses,
we aimed to evaluate whether there is a difference in summary
estimates between studies in which IRSA is deﬁned as ≥2 and
≥3 spontaneous abortions.
Materials and methods
Case-control study
Subjects
In order to test the genetic association between ACE I/D poly-
morphism in intron 16 and IRSA, a case-control study in Slo-
venian women was conducted. One hundred and forty-nine
women with a history of ≥3 consecutive spontaneous abor-
tions of unknown aetiology before the 22nd week of gesta-
tion, with the same partner, and 149 control women were
included in the study. Exclusion criteria for IRSA women were:
endocrine disorders, antiphospholipid syndrome (APS),
autoimmune or systemic diseases, venous or arterial throm-
bosis, uterine anatomical abnormalities detected by ultra-
sonography and/or hysteroscopy, as well as chromosome
abnormalities in either partner. A total of 98 (65.8%) women
had no live births (primary IRSA) and 51 (34.2%) had at least
one live born child (secondary IRSA). Couples with IRSA were
described in more detail elsewhere (Pereza et al., 2012). The
control group consisted of unrelated, healthy women with at
least two live births, and no history of spontaneous abortion
or any other pregnancy complication. All women were re-
cruited through the Clinical Institute of Medical Genetics (UMC
Ljubljana, Slovenia) and gave written informed consent for
participation in the study. The study was approved by Slo-
venian (152/07/09; 2 September 2009) and Croatian Na-
tional Ethics’ Committees (641–01/07–01/19; 28 February
2007).
DNA extraction and molecular analysis
Genomic DNA was extracted from peripheral blood leucocytes
using a commercially available kit (Qiagen_FlexiGene kit;
QIAGEN GmbH, Hilden Germany). Genotyping was per-
formed by allele-speciﬁc PCR as described previously (Rigat
et al., 1992). All PCR were carried out in thermal cyclers
(Mastercycler personal, Eppendorf, Hamburg, Germany and
2720 Thermal Cycler, Applied Biosystems, Carlsbad, CA, USA).
The PCR products were visualized under ultraviolet light after
electrophoresis on 2% agarose gels stained with GelRedTM
(Olerup SSP®, Saltsjöbaden, Sweden).
Systematic review and meta-analysis
Search strategy
The systematic review was carried out using PubMed and
Scopus electronic databases, which were searched for pub-
lications in the English language on the association between
ACE I/D polymorphism in intron 16 and IRSA up to 1 January
2015. The following keywords were used: “recurrent miscar-
riage”, “recurrent pregnancy loss”, “recurrent spontaneous
abortion” + “angiotensin converting enzyme”, “ACE” + “poly-
morphism”, “mutation”. In addition, we searched refer-
ences of retrieved articles. The literature search was
performed by two authors independently and retrieved pub-
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lications were compared to avoid duplication. Any disagree-
ments were discussed and resolved with consensus.
Study selection
The systematic review included all of the retrieved case-
control studies analysing the association of ACE I/D polymor-
phism in intron 16 with IRSA, and written in the English
language. The criteria for inclusion in meta-analysis were: (i)
case-control study in which genotyping was performed in IRSA
women and control women; (ii) RSA deﬁned as ≥2 or ≥3 spon-
taneous abortions; (iii) exclusion of known causes of IRSA ac-
cording to the evidence-based guidelines for the investigation
and medical treatment of RSA provided by the European
Society of Human Reproduction and Embryology (ESHRE; ex-
clusion of APS in women, karyotyping of both partners for ex-
clusion of chromosome abnormalities, ultrasonography
and/or hysteroscopy for exclusion of uterine anatomical ab-
normalities) (Jauniaux et al., 2006); (iv) control group deﬁned
as women with at least one live birth and no spontaneous
abortions; (v) genotyping performed by PCR or sequencing;
(vi) genotype frequencies reported; and (vii) no deviation of
genotype frequencies from Hardy–Weinberg equilibrium (HWE)
in the control group.
Data extraction
For each study included in the systematic review the follow-
ing data were extracted: authors, year of publication, popu-
lation and number of patients and controls, RSA deﬁnition,
exclusion criteria for IRSA women, inclusion criteria for control
women, methods used for genotyping, genotype and allele
frequencies. HWE for genotype frequencies in patient and
control groups for each study were also calculated.
Statistical analysis
Case-control study
Statistical analyses were carried out using Statistica for
Windows, version 10 (StatSoft, Inc., Tulsa, OK, USA) and
MedCalc for Windows, version 14.12.0 (MedCalc Software,
Mariakerke, Belgium). In addition, statistical power was cal-
culated using DSS Researcher’s Toolkit (https://www
.dssresearch.com/KnowledgeCenter/toolkitcalculators/
statisticalpowercalculators.aspx), and deviations from HWE
were tested using the Simple Hardy-Weinberg Calculator–
Court Lab (Washington State University College of Veteri-
nary Medicine, Pullman, WA, USA). Pearson’s chi-squared (χ2)
test was used to test for differences in genotype and allele
frequencies between study groups. Association of geno-
types and alleles with IRSA was estimated by odds ratios (OR)
and 95% conﬁdence intervals (CI) under dominant, recessive
and co-dominant genetic models. P-values <0.05 were con-
sidered statistically signiﬁcant.
Meta-analysis
Meta-analysis was performed using Comprehensive Meta-
Analysis, version 2.2.064 (Biostat, Inc., Englewood, NJ, USA).
Individual and summary OR and associated 95% CI were cal-
culated under dominant and recessive genetic models using
random effects model. Cochran’s Q test was used to assess
heterogeneity, whereas funnel plot and Egger’s regression test
were used to evaluate publication bias. Sensitivity analysis
was performed by removing one study at a time to evaluate
the relative inﬂuence of each study on the pooled estimate.
P-values <0.05 were considered statistically signiﬁcant.
Results
Case-control study
The power of the present study was 100% to detect a twofold
increase in ACE I allele frequency. No statistically signiﬁ-
cant differences were found in the distribution of genotype
and allele frequencies between IRSA and control women or
between women with primary and secondary IRSA (Table 1).
Genotype frequencies were in HWE in all groups. Nor did the
study determine statistically signiﬁcant associations of ACE
I/D polymorphism in intron 16 with IRSA under any genetic
model (Table 2).
Systematic review
The PRISMA ﬂow diagram including the details for the study
searching is shown in Figure 1. Sixteen case-control studies
were identiﬁed on the association between ACE I/D polymor-
phism in intron 16 and IRSA (Table 3). All articles were written
in the English language. Molecular analysis was appropriate
in all studies. Twelve studies deﬁned IRSA as ≥2 spontane-
ous abortions (Aarabi et al., 2011; Buchholz et al., 2003;
Bukreeva et al., 2009; Corbo et al., 2011;
Dossenbach-Glaninger et al., 2008; Goodman et al., 2009; Kim
et al., 2014; Ozdemir et al., 2012; Poursadegh Zonouzi et al.,
Table 1 Genotype and allele frequencies of ACE I/D polymorphism in intron 16 in IRSA women, control women and women with
primary and secondary IRSA.
Genotype frequencies/n (%) Allele frequencies/n (%)
DD ID II χ2; P HWE/χ2; P D I χ2; P
IRSA 43 (28.9) 75 (50.3) 31 (20.8) 2.72; 0.257 0.03;0.871 161 (54.0) 137 (46.0) 0.68; 0.409
Control 55 (36.9) 62 (41.6) 32 (21.5) 3.24;0.072 172 (57.7) 126 (42.3)
Primary IRSA 31 (31.6) 48 (49.0) 19 (19.4) 1.14; 0.564 0.00;0.957 110 (56.1) 86 (43.9) 0.78; 0.377
Secondary IRSA 12 (23.5) 27 (52.9) 12 (23.5) 0.18;0.674 51 (50.0) 51 (50.0)
HWE, Hardy-Weinberg equilibrium; IRSA, idiopathic recurrent spontaneous abortion; χ2, chi-squared test.
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2013; Vettriselvi et al., 2008; Yenicesu et al., 2010; Zhang
et al., 2011), and the remaining four deﬁned it as ≥3 spon-
taneous abortions (Al Sallout and Sharif, 2010; Bagheri et al.,
2010; Choi et al., 2011; Fatini et al., 2000).
In the group of studies deﬁning IRSA as ≥2 spontaneous abor-
tions, inclusion criteria for control groups and IRSA women
according to ESHRE criteria (Jauniaux et al., 2006) were ap-
propriately deﬁned in six studies (Buchholz et al., 2003; Kim
et al., 2014; Ozdemir et al., 2012; Poursadegh Zonouzi et al.,
2013; Vettriselvi et al., 2008; Yenicesu et al., 2010); however,
genotype frequencies signiﬁcantly deviate from HWE in the
study by Vettriselvi et al. (2008), and it was not possible to
calculate genotype and allele frequencies from the manner
in which they were presented in the original paper by Yenicesu
et al. (2010). The other six studies either had no patient se-
lection criteria described (Bukreeva et al., 2009; Corbo et al.,
Table 2 Association of ACE I/D polymorphism in intron 16 with IRSA under different genetic
models.
Genetic model
WIRSA versus WC WPrimary IRSA versus WSecondary IRSA
OR (95% CI) P OR (95% CI) P
Dominant:
Recessive:
Co-dominant:
Alleles:
DD + ID vs. II
DD vs. ID + II
DD vs. II
DD vs. ID
II vs. ID
D vs. I
1.04 (0.60–1.81)
0.69 (0.43–1.13)
0.81 (0.43–1.52)
0.65 (0.38–1.09)
0.80 (0.44–1.45)
0.86 (0.62–1.19)
0.887
0.140
0.508
0.101
0.466
0.364
1.28 (0.56–2.90)
1.50 (0.69–3.26)
1.63 (0.61–4.36)
1.45 (0.64–3.29)
0.89 (0.37–2.11)
1.28 (0.79–2.07)
0.555
0.302
0.329
0.370
0.792
0.315
CI, conﬁdence interval; IRSA, idiopathic recurrent spontaneous abortion; OR, odds ratio; WIRSA,
IRSA women; WC, control women; WPrimary/Secondary IRSA, women with primary or secondary IRSA.
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Figure 1 PRISMA ﬂow diagram showing the process of literature searching and selection criteria for inclusion in the systematic review
and meta-analysis.
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Table 3 Characteristics of IRSA and control women included in case-control studies on the association between ACE I/D polymor-
phism in intron 16 and IRSA.
Authors
Population Number of
patients and
controls
RSA deﬁnition Exclusion criteria in IRSA women Inclusion criteria
for control women
APS CA UA Other SA Number of
children
Buchholz et
al., 2003
German P: 184 W
C: 127 W
≥2 consecutive SA
before 25 WOG
+ + + endocrine disorders, protein C, S
and antithrombin III deﬁciencies
0 ≥1
Dossenbach-
Glaninger
et al., 2008
Austrian P: 49 W
C: 48 W
2 consecutive or 3–6
non-consecutive SA
between 8 and 12
WOG
ND +/−a + endocrine and autoimmune
disorders, infections, inﬂammatory
pelvic disease, arterial
hypertension, pregnancy
complications or assisted
reproduction, liver abnormalities
0 ≥1
Vettriselvi et
al., 2008
Indian P: 104 W
C: 120 W
≥2 consecutive SA
before 20 WOG, with
the same partnerb
+ + + endocrine and autoimmune
disorders, infections, pregnancy
complications
0 ≥2
Bukreeva et
al., 2009
German P: 177 W
C1: 527 W
C2: 553 W
≥2 SA in ﬁrst
trimester
ND ND ND C1: VTE, UPD, ATD
C2: without SA, VTE,
UPD, ATD
Goodman et
al., 2009
American P: 120 W
C: 84 W
≥2 consecutive SA + + + autoimmune disorders ≤1 ≥2
Yenicesu et
al., 2010
Turkish P: 272 W,
152 M
C: 56 Co
≥2 consecutive SA
between 5 and 12
WOG, with the same
partnerb
+ + + endocrine and autoimmune
disorders, urogenital infections
0 ≥2
Aarabi et al.,
2011
Iranian P: 63 W
C: 114 W
≥2 consecutive SA
before 25 WOG
ND ND + endocrine and autoimmune
disorders, urogenital infections,
inﬂammatory pelvic disease
0 ND
Corbo et al.,
2011
Italian P: 18 Wc
C: 47 W
≥2 SA ND ND ND ND ND
Zhang et al.,
2011
Chinese P: 127 W
C:132 W
≥2 consecutive SA in
early pregnancyb
+ + + endocrine and autoimmune
disorders, infections, hereditary
thrombophilia
ND NDd
Ozdemir et
al., 2012
Turkish P: 543 W,
327 M
C: 106 Co
≥2 consecutive SA
between 5 and 12
WOG, with the same
partnerb
+ + + endocrine and autoimmune
disorders, urogenital infections
0 ≥1
Poursadegh
Zonouzi et
al., 2013
Iranian P: 89 W
C: 50 W
≥2 consecutive SA + + + endocrine disorders, urogenital
infections
0 ≥2
Kim et al.,
2014.
Korean P: 227 W
C: 304 W
≥2 consecutive SA
before 20 WOG
+ + + endocrine and autoimmune
disorders
0 ≥2
Fatini et al.,
2000
Italian P: 59 W
C: 70 W
≥3 SA between 7 and
12 WOG
+ - - endocrine disorders, arterial or
venous thromboembolism,
pregnancy complications,
hypertension
ND ND
Al Sallout and
Sharif,
2010
Palestinian P: 100 W
C: 100 W
≥3 consecutive SA
before 25 WOG
+ ND ND infections 0 ≥1
Bagheri et al.,
2010
Iranian P: 50 W
C: 63 W
≥3 SA before 20
WOG, with the same
partner
+ + + endocrine and immune disorders,
infections, protein C, S and
antithrombin III deﬁciencies
ND ≥2
Choi et al.,
2011
South Korean P: 251 W
C: 126 W
≥3 consecutive SA
before 20 WOGe
ND + + endocrine and autoimmune
disorders, infections, arterial or
venous thromboembolism, family
history of IRSA
0 ≥1
Present study Slovenian P: 149 W
C: 149 W
≥3 SA before 22
WOG, with the same
partner
+ + + endocrine and autoimmune
disorders, arterial or venous
thrombosis
0 ≥2
APS, antiphospholipid syndrome; ATD, atherothrombotic disease; C, controls; CA, chromosome abnormalities; Co, couples; IRSA, idiopathic recurrent sponta-
neous abortion; M, men; ND, not described; P, patients; SA, spontaneous abortion; UA, uterine anomalies; UPD, uteroplacental dysfunction; VTE, venous throm-
boembolism; W, women; WOG, weeks of gestation.
aAvailable for 50% of women.
bPrimary IRSA.
cAuthors indicate that all participants were enrolled without selection criteria.
dMultipara women were included, but the minimum number of children is not indicated.
e225 women with primary and 26 women with secondary IRSA.
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2011), excluded the known causes of IRSA partially (Aarabi
et al., 2011; Dossenbach-Glaninger et al., 2008) or did not
deﬁne the inclusion criteria for the control group properly
(Goodman et al., 2009; Zhang et al., 2011). In the study by
Aarabi et al. (2011), genotype data were available for 94, not
114 control women as indicated in the paper. In three out of
twelve studies, a statistically signiﬁcantly higher frequency
of the D allele was found in IRSA women compared with con-
trols (Table 4) (P = 0.006 in Corbo et al., 2011; P < 0.038 in
Zhang et al., 2011; P < 0.001 in Ozdemir et al., 2012).
In the second group of studies, in which IRSA was deﬁned
as ≥3 spontaneous abortions, none of the four studies se-
lected both the IRSA and the control group appropriately: the
mandatory diagnostic evaluations in IRSA women were par-
tially performed in three studies (Al Sallout and Sharif, 2010;
Choi et al., 2011; Fatini et al., 2000), and the inclusion cri-
teria for the control group were unsuitable in the studies by
Bagheri et al. (2010) and Fatini et al. (2000). The only reli-
able genotype data for women with ≥3 spontaneous abor-
tions is mentioned in the study by Kim et al. (2014), who
deﬁned IRSA as ≥2 spontaneous abortions but presented the
results for women with ≥3 spontaneous abortions sepa-
rately. Statistically signiﬁcantly higher frequency of the D allele
was determined in IRSA women compared with controls in two
studies (P < 0.001 in Zhang et al., 2011; P = 0.019 in Fatini
et al., 2000), whereas the I allele was more frequent in IRSA
women in one study (P = 0.025 in Choi et al., 2011) (Table 4).
Meta-analysis
The inclusion criteria for meta-analysis were met in four
studies in which IRSA was deﬁned as ≥2 spontaneous abor-
tions (Buchholz et al., 2003; Kim et al., 2014; Ozdemir et al.,
2012; Poursadegh Zonouzi et al., 2013). Considering that
women with ≥3 spontaneous abortions also satisfy the deﬁ-
nition of ≥2 spontaneous abortions, our study was included
in this meta-analysis, which was then performed on a total
of ﬁve studies. Quantitative synthesis was performed just for
this group of studies because only two studies in which IRSA
was deﬁned as ≥3 spontaneous abortions fulﬁlled the afore-
mentioned criteria (present study; Kim et al., 2014).
The four studies in which IRSA was deﬁned as ≥2 sponta-
neous abortions and thepresent study inwhich IRSAwasdeﬁned
as ≥ 3 spontaneous abortions included 1192 patients and 736
controls (Tables 3 and 4). Based on random effects model,
the association ofACE I/D polymorphism in intron 16with IRSA
was not statistically signiﬁcant under the dominant (DD + ID
versus II) or recessive genetic models (DD versus ID + II)
(Figures 2 and 3). High among-study heterogeneity was
observed under both dominant (Cochran’s Q test: χ2 = 21.79;
df = 4; P = 0.000; Higgins statistics: I2 = 81.65%) and recessive
geneticmodels (Cochran’s Q test: χ2 = 19.12; df = 4; P = 0.001;
Higgins statistics: I2 = 79.08%). No publication bias was de-
tected in either genetic model (dominant: t = 0.40; df = 3;
P = 0.718; recessive: t = 0.66; df = 3; P = 0.555).
Discussion
In the present study an extensive examination of the role of
ACE I/D polymorphism in intron 16 in IRSA women was per-
formed through a case-control study, systematic review and
meta-analysis.
The results of the case-control study suggest that ACE I/D
polymorphism in intron 16 is not associated with IRSA in Slo-
venian women. Although it was not possible to include this
study in a meta-analysis of studies deﬁning IRSA as ≥3 spon-
taneous abortions, the results are comparable with those ob-
tained in the only study in which women with ≥3 spontaneous
abortions and control women were selected appropriately (Kim
et al., 2014). Although the distribution of genotype frequen-
cies between these studies is slightly different, this could prob-
ably be attributed to population differences.
The second aim of this study was to perform a search of
the available scientiﬁc literature on the association of ACE
I/D polymorphism in intron 16 with IRSA. We recently pointed
to signiﬁcant inconsistencies between studies regarding the
selection criteria for patients and controls, as well as the fact
that only a minority of studies comply with the available guide-
lines for IRSA provided by different professional societies
(Pereza et al., 2015). Unfortunately, the results of such in-
adequately designed studies, including meta-analyses, may
be misleading, creating unfounded assumptions on associa-
tions with IRSA. The present systematic review, in which 16
case-control studies were identiﬁed that investigated the ACE
I/D polymorphism in intron 16 in IRSA women, conﬁrms our
previous conclusions on discrepancies between studies. The
most notable differences observed concern IRSA deﬁnition,
designation and exclusion of known causes of IRSA, and se-
lection criteria for control women. We would like to empha-
size that the studies in which the criteria for the selection
of IRSA patients were not described (Bukreeva et al., 2009;
Corbo et al., 2011), or known causes of IRSA were only par-
tially eliminated (Aarabi et al., 2011; Al Sallout and Sharif,
2010; Choi et al., 2011; Dossenbach-Glaninger et al., 2008)
were included in previously conducted meta-analyses (Su
et al., 2013; Wang et al., 2013; Yang et al., 2012). In addi-
tion, the current systematic review shows that studies in which
RSA is deﬁned as ≥2 spontaneous abortions constitute the ma-
jority of case-control studies on the association between ACE
I/D polymorphism in intron 16 and IRSA (12/16 or 75%). Al-
though the reasons for choosing the less strict deﬁnition of
RSA are beyond the scope of this article, we recommend that
research groups that deﬁne IRSA as ≥2 spontaneous abor-
tions present results for women/couples with ≥3 spontane-
ous abortions separately.
The third aim of this study was to perform the quantita-
tive synthesis of results of studies with properly conducted
diagnostic evaluations deﬁned by ESHRE in IRSA women
(couples) and a well-deﬁned control group. We particularly
wanted to evaluate whether there is a difference between
summary estimates regarding the studies in which RSA is
deﬁned as ≥2 and ≥3 spontaneous abortions. Unfortunately,
it was not possible to perform the comparison due to deﬁ-
cient selection criteria applied in original studies with themore
rigorous deﬁnition. Consequently, a meta-analysis was per-
formed that included four studies in which IRSA was deﬁned
as ≥2 spontaneous abortions and the current study, which
deﬁned IRSA as ≥3 spontaneous abortions, yielding negative
results. When comparing this meta-analysis to those previ-
ously conducted, two major differences were observed (Su
et al., 2013; Wang et al., 2013; Yang et al., 2012). The ﬁrst
difference is in the summary odds ratios. In contrast to our
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Table 4 Genotype and allele frequencies obtained in case-control studies on the association between ACE I/D polymorphism in intron
16 and IRSA.
Authors
Genotype frequencies [n (%)]
II / ID / DD
χ2; P HWE; P-value Allele frequencies [n (%)]
I / D
χ2; P-value
Buchholz et
al., 2003
WIRSA: 42 (22.8) / 83 (45.1) / 59
(32.1)
WC: 26 (20.5) / 71 (55.9) / 30 (23.6)
3.83; 0.147 0.222;
0.179
WIRSA: 167 (45.4) / 201 (54.6)
WC: 123 (48.4) / 131 (51.6)
0.44; 0.505
Dossenbach-
Glaninger et
al., 2008
WIRSAa: 12 (24.5) / 20 (40.8) / 17
(34.7)
WC: 12 (25.0) / 29 (60.4) / 7 (14.6)
5.81; 0.055 0.220;
0.125
WIRSA: 44 (44.9) / 54 (55.1)
WC: 53 (55.2) / 43 (44.8)
1.67; 0.196
Vettriselvi et
al., 2008
WIRSA: 42 (40) / 39 (38) / 23 (22)
WC: 55 (46) / 38 (31) / 27 (23)
0.94; 0.630 0.022;
< 0.001
WIRSA: 123 (59.1) / 85 (40.9)
WC: 148 (61.7) / 92 (38.3)
0.20; 0.653
Bukreeva et
al., 2009
WIRSAb: -
WC1: 136 (25.8) / 241 (45.7) / 150
(28.5)
WC2: 140 (25.3) / 254 (45.9) / 159
(28.8)
− 0.052;
0.059
WIRSAb: −
WC1: 513 (48.7) / 541 (51.3)
WC2: 534 (48.3) / 572 (51.7)
−
Goodman et
al., 2009
WIRSA: 31 (25.8) / 55 (45.8) / 34
(28.3)
WC: 22 (26.2) / 34 (40.5) / 28 (33.3)
0.73; 0.693 0.365;
0.088
WIRSA: 117 (48.8) / 123 (51.2)
WC: 78 (46.4) / 90 (53.6)
0.13; 0.718
Yenicesu et
al., 2010c
Aarabi et al.,
2011
WIRSAd: 14 (22.2) / 30 (47.6) / 19
(30.2)
WC: 22 (23.4) / 47 (50.0) / 25 (26.6)
0.24; 0.888 0.741;
0.992
WIRSAd: 58 (46.0) / 68 (54.0)
WC: 91 (48.4) / 97 (51.6)
0.09; 0.766
Corbo et al.,
2011
WIRSAe: 0 (0) / 6 (33.0) / 12 (67.0)
WCf: 11 (23.0) / 20 (43.0) / 16
(34.0)
7.70; 0.021 0.396;
0.340
WIRSAe: 6 (16.7) / 30 (83.3)
WCf: 42 (44.7) / 52 (55.3)
7.61; 0.006
Zhang et al.,
2011
WIRSA1e: 49 (57.0) / 26 (30.2) / 11
(12.8)
WIRSA2d: 8 (19.5) / 23 (56.1) / 10
(24.4)
WC: 90 (68.2) / 34 (25.8) / 8 (6.0)
1g: 4.11; 0.128
2h: 31.92; < 0.001
0.021;
0.425;
0.064
WIRSA1: 124 (72.1) /48 (27.9)
WIRSA2: 39 (47.6) / 43 (52.4)
WC: 214 (81.1) / 50 (18.9)
1g: 4.31; 0.038
2h: 34.04; < 0.001
Ozdemir et
al., 2012
WIRSA: 71 (13.1) / 260 (47.8) / 212
(39.0)
WC: 33 (31.9) / 54 (50.0) / 19 (18.1)
29.33; < 0.001 0.531;
0.703
WIRSA: 402 (37.0) / 684 (63.0)
WC: 120 (56.6) / 92 (43.4)
27.50; < 0.001
Poursadegh
Zonouzi et
al., 2013
WIRSA: 23 (25.9) / 31 (34.8) / 35
(39.3)
WC: 7 (14.0) / 28 (56.0) / 15 (30.0)
6.23; 0.044 0.006;
0.291
WIRSA: 77 (43.2) / 101 (56.8)
WC: 42 (42.0) / 58 (58.0)
0.01; 0.938
Kim et al.,
2014
WIRSA1e: 83 (36.6) / 110 (48.5) / 34
(15.0)
WIRSA2d: 51 (35.7) / 71 (49.7) / 21
(14.7)
WC: 104 (34.2) / 148 (48.7) / 52
(17.1)
1g: 0.57; 0.752
2h: 0.43; 0.808
0.803;
0.643;
0.958
WIRSA1e: 276 (60.8) / 178 (39.2)
WIRSA2d: 173 (60.5) / 113 (39.5)
WC: 356 (58.6) / 252 (41.4)
1g: 0.45; 0.501
2h: 0.23; 0.634
Fatini et al.,
2000
WIRSA: 10 (16.9) / 21 (35.6) / 28
(47.5)
WC: 20 (28.6) / 30 (42.8) / 20 (28.6)
5.36; 0.069 0.098;
0.232
WIRSA: 41 (35.0) / 77 (65.0)
WC: 70 (50.0) / 70 (50.0)
5.47; 0.019
Al Sallout and
Sharif, 2010
WIRSA: 9 (9.0) / 42 (42.0) / 49 (49.0)
WC: 12 (12.0) / 34 (34.0) / 54 (54.0)
1.51; 0.469 1.000;
0.081
WIRSA: 60 (30.0) / 140 (70.0)
WC: 58 (29.0) / 142 (71.0)
0.01; 0.913
Bagheri et al.,
2010
WIRSA: 7 (14.0) / 26 (52.0) / 17
(34.0)
WC: 12 (19.0) / 27 (42.9) / 24 (38.1)
1.05; 0.592 0.556;
0.380
WIRSA: 40 (40.0) / 60 (60)
WC: 51 (40.5) / 75 (59.5)
0.00; 0.949
Choi et al.,
2011
WIRSA: 77 (30.7) / 130 (51.8) / 44
(17.5)
WC: 35 (27.8) / 50 (39.7) / 41 (32.5)
11.20; 0.004 0.391;
0.022
WIRSA: 284 (56.6) / 218 (43.4)
WC: 120 (47.6) / 132 (52.4)
5.05; 0.025
HWE, Hardy-Weinberg equilibrium; χ2, chi-square test; WIRSA, IRSA women; WC, control women.
aData taken from Su et al. (2013).
bGenotype and allele frequencies were not shown separately for IRSA women.
cNumbers for genotype and allele frequencies were not shown.
dWomen with ≥3 spontaneous abortions.
eWomen with ≥2 spontaneous abortions.
fWomen without spontaneous abortions.
gWIRSA1 versus Wc.
hWIRSA2 versus Wc.
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results, all three published meta-analyses detected a statis-
tically signiﬁcant association of ACE I/D polymorphism in intron
16 with IRSA deﬁned as ≥2 spontaneous abortions, accord-
ing to the dominant model (DD + ID versus II) using random
effects model. However, the association was lost when women
with ≥3 spontaneous abortions were analysed separately, which
is contrary to expectations and difﬁcult to explain because
it would be logical for the association to grow stronger as the
number of spontaneous abortions increases. The second dif-
ference concerns the inclusion criteria applied for the process
of studies selection for meta-analysis. For instance, Wang et al.
(2013) and Su et al. (2013) used the same criteria, in which
protein C/S and antithrombin-III deﬁciencies are indicated as
proven causes of IRSA, which has not been conﬁrmed (Jauniaux
et al., 2006). Also, in none of the three meta-analyses was
the selection of studies performed in accordance with the pro-
posed criteria. Only as an example, the protein C/S and
antithrombin-III deﬁciencies were excluded in just two origi-
nal case-control studies. Therefore, although meta-analyses
are an important part of evidence-based medicine, the eli-
gibility criteria should be thoroughly evaluated before ac-
cepting the conclusions. Although no association was found
between ACE I/D polymorphism in intron 16 and women with
≥2 spontaneous abortions (including our study with the more
rigorous deﬁnition of ≥3 spontaneous abortions), the result
is based only on ﬁve studies, all of which were conducted in
different populations. Thus, well-designed case-control studies
are needed to evaluate the role of this variation in IRSA, es-
pecially IRSA deﬁned as ≥3 spontaneous abortions.
The ACE I/D polymorphism in intron 16 has been investi-
gated in a large number of studies as a factor of predisposi-
tion to various complex diseases, such as Alzheimer’s disease,
coronary heart disease and pre-eclampsia (Petrovic and
Peterlin, 2004; Staines-Urias et al., 2012). The D allele and
the DD genotype have emerged as potential risk factors for
some of these diseases. However, as a consequence of
contradictory results, strong evidence of such associations
is still missing (Sayed-Tabatabaei et al., 2006). The
Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper Relative
ratio limit limit Z-Value p-Value weight
Buchholz et al. 2003 0,870 0,501 1,511 -0,493 0,622 20,37
Ozdemir et al. 2012 3,005 1,858 4,861 4,485 0,000 21,40
Poursadegh Zonouzi et al. 2013 0,467 0,184 1,183 -1,606 0,108 14,90
Kim et al. 2014 0,902 0,630 1,292 -0,562 0,574 23,02
Present study 1,041 0,597 1,816 0,142 0,887 20,31
1,081 0,620 1,887 0,275 0,783
0,01 0,1 1 10 100
Favours A Favours B
Figure 2 Forest plot for the meta-analysis of ACE I/D polymorphism in intron 16 under dominant genetic model (DD+ID versus II)
using random effects model.
Study name Statistics for each study Odds ratio and 95% CI
Odds Lower Upper Relative
ratio limit limit Z-Value p-Value weight
Buchholz et al. 2003 1,526 0,913 2,550 1,614 0,107 20,54
Ozdemir et al. 2012 2,933 1,734 4,960 4,014 0,000 20,35
Poursadegh Zonouzi et al. 2013 1,512 0,722 3,168 1,096 0,273 16,94
Kim et al. 2014 0,854 0,533 1,368 -0,658 0,511 21,20
Present study 0,693 0,426 1,127 -1,477 0,140 20,97
1,304 0,773 2,201 0,995 0,320
0,01 0,1 1 10 100
Favours A Favours B
Figure 3 Forest plot for the meta-analysis of ACE I/D polymorphism in intron 16 under recessive genetic model (DD versus II+ID)
using random effects model.
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pathophysiologic consequences of this polymorphism in IRSA
are almost completely unknown. The effect of different geno-
types on plasma or local levels of ACE, other RAS compo-
nents or peptides related to the activity of ACE or ANG II have
not been sufﬁciently evaluated in IRSA women. Only one such
study was conducted in which the association between ACE
DD genotype and PAI-1 was tested, but the results were
negative (Fatini et al., 2000). Accordingly, in addition to
genetic-association studies, functional studies are needed to
explain the role of ACE I/D polymorphism in intron 16 in IRSA
on the systemic and local, uteroplacental levels. Until then
we may only speculate about its pathophysiologic signiﬁ-
cance in IRSA, which could include alterations in ACE plasma
or local levels, as well as affects on any functions that ACE
and downstream peptides exert in normal pregnancy, such
as regulation of trophoblast invasion, angiogenesis,
fetoplacental circulation, haemostasis and synthesis of dif-
ferent enzymes.
The limitations of this meta-analysis are the small number
of studies included in the quantitative synthesis, as well as
the among-study heterogeneity that was detected under both
dominant and recessive genetic models. For that reason, the
meta-analyses was conducted using the random effects model.
The heterogeneity may be the consequence of population dif-
ferences, i.e. different distribution of genotype frequen-
cies. On the other hand, we performed a case-control study
with rigorous inclusion criteria for IRSA and control groups.
The systematic review was comprehensive and selection cri-
teria for inclusion in meta-analysis strict and based on ESHRE
evidence-based guidelines for the diagnosis of IRSA, allow-
ing studies with well-chosen participants to be selected.
In conclusion, we found no association of ACE I/D poly-
morphism in intron 16 with IRSA in Slovenian women. In the
systematic review, 16 case-control studies were identiﬁed,
showing notable differences regarding IRSA deﬁnition, as well
as the selection criteria for IRSA and control women. Finally,
the results of meta-analyses conducted on ﬁve well-designed
studies did not provide evidence for an association between
ACE I/D polymorphism in intron 16 and women with IRSA ≥2
spontaneous abortions.
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